Trade with Eva: Analytics in action >>
Showing posts with label dividend stocks. Show all posts
Showing posts with label dividend stocks. Show all posts

Monday, October 21, 2024

10 large-cap stocks whose dividend yield is more than 4%

                 Forward Dividend & Yield

  • Rio Tinto Group (RIO)   4.35 (6.66%)
  • Verizon Communications Inc. (VZ)  2.71 (6.16%)
  • Pfizer Inc. (PFE)  1.68 (5.75%)
  • TotalEnergies SE (TTE)  3.43 (5.28%)
  • BHP Group Limited (BHP)  2.92 (5.11%) 
  • AT&T Inc. (T)  1.11 (5.08%)
  • United Parcel Service, Inc. (UPS)   6.52 (4.80%)
  • Philip Morris International Inc. (PM)    5.40 (4.49%)
  • Chevron Corporation (CVX)  6.52 (4.33%)
  • Shell plc (SHEL)  2.75 (4.11%)
T - AT&T, Inc. - Stock Price Chart PFE - Pfizer Inc. - Stock Price Chart VZ - Verizon Communications Inc - Stock Price Chart CVX - Chevron Corp. - Stock Price Chart PM - Philip Morris International Inc - Stock Price Chart UPS - United Parcel Service, Inc. - Stock Price Chart RIO - Rio Tinto plc ADR - Stock Price Chart SHEL - Shell Plc ADR - Stock Price Chart BHP - BHP Group Limited ADR - Stock Price Chart TTE - TotalEnergies SE ADR - Stock Price Chart

Wednesday, October 16, 2024

MetroCity Bankshares (MCBS) increases quarterly cash dividend to $0.23/share

MetroCity Bankshares increases quarterly cash dividend to $0.23/share from $0.20/share and announces the continuation of its share repurchase program 
  • The Company approves the continuation of its share repurchase program that expired on September 30, 2024 and authorized the Company to repurchase up to 925,250 shares of the Company's outstanding shares of common stock, which is the number of remaining shares authorized for repurchase from the Prior Share Repurchase Plan.
  • The share repurchase program will begin on October 17, 2024 and end on September 30, 2025.
Earnings DateOct 18, 2024
Forward Dividend & Yield0.80 (2.58%)
Ex-Dividend DateJul 31, 2024
Dividend Payable Date    Aug 9, 2024

X: Oct 10, vol. 17K

 
 



Wednesday, June 19, 2024

Algonquin Power & Utilities (AQN)

Forward Dividend & Yield0.43 (7.42%)
Ex-Dividend DateJun 28, 2024
 

Sector(s): Utilities
Industry: Utilities - Renewable

Monday, June 3, 2024

AGNC Investment Corp. (AGNC)


Forward dividend & yield1.44 (15.00%)
Ex-dividend date31 May 2024
 
 





Wednesday, May 22, 2024

M&T Bank (MTB) increases quarterly cash dividend 4% to $1.35/share from $1.30/share


Earnings DateJul 18, 2024
Forward Dividend & Yield5.40 (3.58%)
Ex-Dividend DateJun 03, 2024


Friday, May 17, 2024

Realty Income (O) increases quarterly cash dividend 2.1% to $0.2625/share

 Realty Income increases quarterly cash dividend 2.1% to $0.2625/share from $0.257/share

Forward Dividend & Yield3.08 (5.59%)
Ex-Dividend DateApr 30, 2024

 

Sunday, February 18, 2024

Alliant Energy Corporation (LNT)

Forward Dividend & Yield1.92 (3.97%)
Ex-Dividend DateJan 30, 2024
 
Alliant Energy Corporation was incorporated in 1981 and is headquartered in Madison, Wisconsin.
Sector(s)Utilities
IndustryUtilities - Regulated Electric


 


Friday, May 8, 2020

Kimco Realty (KIM) reported earnings on Fri 8 May 20 (a/h)

  • Open-air mall operator; considered essential business during the pandemic (Walmart, grocery stores, etc.)
  • Forward Dividend & Yield 1.12 (11.14%)


Kimco Realty beats by $0.01, reports revs in-line


  • Reports Q1 (Mar) funds from operations of $0.37 per share, $0.01 better than the S&P Capital IQ Consensus of $0.36; revenues fell 3.5% year/year to $284.7 mln vs the $283.35 mln S&P Capital IQ Consensus.
  • Attained pro-rata anchor occupancy of 98.6%, an increase of 80 basis points from first quarter 2019.
  • Grew same-property net operating income (NOI) 1.5% compared to the same period in 2019.
  • Wednesday, February 12, 2020

    Nu Skin (NUS) reported earnings on Wed 12 Feb 20 (a/h)

    ** charts after earnings **

     


     
     

    Nu Skin increases quarterly cash dividend to $0.375/share from $0.370/share

    Nu Skin reports EPS in-line, revs in-line; guides Q1 EPS below consensus, revs below consensus; guides FY20 EPS below consensus, revs below consensus

  • Reports Q4 (Dec) earnings of $0.72 per share, in-line with the S&P Capital IQ Consensus of $0.72; revenues fell 14.6% year/year to $583.36 mln vs the $582.49 mln S&P Capital IQ Consensus.
  • Co issues downside guidance for Q1, sees EPS of $0.23-0.33 vs. $0.74 S&P Capital IQ Consensus; sees Q1 revs of $480-510 mln vs. $596.6 mln S&P Capital IQ Consensus.
  • Co issues downside guidance for FY20, sees EPS of $2.00-2.40 vs. $3.31 S&P Capital IQ Consensus; sees FY20 revs of $2.17-2.30 bln vs. $2.47 bln S&P Capital IQ Consensus.
  • Coronavirus Impact: Following the recent coronavirus outbreak, co has placed a temporary hold on all in-person meetings with its sales force and customers in Mainland China. While co expects the outbreak to significantly impact its business in the near term, co remains confident in its long-term opportunity in Mainland China and around the world. Its guidance reflects our current understanding of the situation.
  • Friday, November 1, 2019

    AbbVie (ABBV) reported earnings on Fri 1 Nov 2019 (b/o)

    ** charts after earnings **
     
     

    AbbVie topped third-quarter estimates and announced a 10.3% increase to its dividend in 2020.

    During the third quarter, AbbVie earned $2.33 per share, minus certain items. AbbVie earnings increased roughly 9% year over year and beat the forecast of analysts polled by Zacks Investment Research for $2.29 per share. Sales grew 3% to $8.48 billion, above estimates for $8.41 billion.

    Chief Executive Richard Gonzalez credited the third-quarter strength to AbbVie's immunology unit and blood cancer treatments.

    "We are also making excellent progress with several key strategic priorities, including the recent launch of our two new immunology therapies — Rinvoq and Skyrizi — both of which are off to an impressive start, as well as continued progress toward the completion of our planned acquisition of Allergan (AGN)," he said in a written statement.

    AbbVie Earnings, Sales Top Estimates
    Sales of AbbVie's most important product, Humira, were mixed. Humira, which treats forms of arthritis and psoriasis as well as Crohn's disease, is facing biosimilar competition in Europe. As a result, global Humira sales slipped 3.7% to $4.94 billion.

    The pain was acute in international business. Humira sales plunged 33.5% to $1.05 billion. The Street expected this, however. In the U.S., Humira continued its momentum and sales increased 9.6% to $3.89 billion. Biosimilars will launch in the U.S. in 2023.

    Revenue from blood cancer treatments jumped 38.3% to $1.48 billion. But sales from hepatitis C drugs tumbled 19% to $698 million. The market for hepatitis C treatments is maturing in the U.S. and Europe. There's also plenty of competition.

    AbbVie Stock Rises On Dividend Boost
    Based on the results, AbbVie raised its full-year earnings outlook to $8.90-$8.92, up 4 cents at the midpoint from its prior guidance. Analysts projected AbbVie earnings of $8.93. So, AbbVie's guidance was slightly short.

    The pharmaceutical company also announced a plan to increase its quarterly cash dividend to $1.18 per share, up from $1.07 previously. This will begin with the dividend payable Feb. 14 to investors who own AbbVie stock as of Jan. 15.

    Friday, October 11, 2019

    Fastenal (FAST) reported earnings on Fri 11 Oct 19 (b/o)

    ** charts after earnings **



     









    Fastenal beats by $0.01, reports revs in-line 
    Fastenal increases quarterly dividend to $0.22/share from $0.215/share

    Forward Dividend & Yield0.88 (2.84%)



  • Reports Q3 (Sep) earnings of $0.37 per share, $0.01 better than the S&P Capital IQ Consensus of $0.36; revenues rose 7.8% year/year to $1.38 bln vs the $1.38 bln S&P Capital IQ Consensus.
  • "We continue to expect our net capital expenditures in 2019 to be within a range of $195.0 to $225.0, an increase from $166.8 in 2018. This increase is a result of higher spending for property and equipment to expand our hub capacity, vending devices, and hub vehicles. The progress of our investments in hub capacity will likely be the primary determinant of where we fall within our range."
  • Thursday, August 8, 2019

    -=Kraft Heinz (KHC) reported earnings on Thur 8 Aug 2019 (b/o)

    The Chicago-based company earned $1.44 per share, compared with $1.89 a year earlier. Kraft Heinz said net sales fell about 5% to $12.37 billion.
    • Forward Dividend & Yield
    1.60 (4.92%)



    Kraft Heinz reports 1H19 results, CEO says level of decline experienced in the first half of this year "is nothing we should find acceptable moving forward"; Co sees brief delay in filing Q2 

  • Q1:
    • Reports Q1 earnings of $0.66 per share, excluding non-recurring items, $0.05 better than the S&P Capital IQ Consensus of $0.61; revenues fell 5.5% year/year to $5.96 bln vs the $6.07 bln S&P Capital IQ Consensus.
  • Q2:
    • Reports Q2 earnings of $0.78 per share, excluding non-recurring items, $0.03 better than the S&P Capital IQ Consensus of $0.75; revenues fell 4.2% year/year to $6.41 bln vs the $6.59 bln S&P Capital IQ Consensus.
  • In connection with the preparation of the first and second quarter financial statements, which occurred concurrently due to the delayed filing of the 2018 Form 10-K, the Company concluded that the fair values of certain goodwill and intangible assets were below their carrying amounts. As a result, the Company recorded non-cash impairment charges to lower the carrying amount of goodwill in certain reporting units (EMEA East, Brazil, United States Refrigerated, and Latin America Exports) by approximately $744 million, primarily based on new five-year operating forecasts for several international businesses that establish revised expectations and priorities for the coming years in response to current market factors. In addition, the Company recorded non-cash impairment charges(3) of approximately $474 million to lower the carrying amount of certain intangible assets, primarily driven by the application of a higher discount rate to reflect the markets' perceived risk in the Company's valuation.
  • "The level of decline we experienced in the first half of this year is nothing we should find acceptable moving forward," said Kraft Heinz CEO Miguel Patricio. "We have significant work ahead of us to set our strategic priorities and change the trajectory of our business. But in my short time with the company, I have developed a strong appreciation for the affinity consumers around the world continue to have for our brands, the talent and determination of our employees, as well as the commitment of our customers. We have a lot to work with and build upon, and our team is motivated by the opportunity to drive the next phase of growth and profitability for Kraft Heinz and our shareholders."
  • The Company is also filing a Form 12b-25 with the SEC today, disclosing that while the Company is unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 29, 2019 (the "Q2 Form 10-Q") by the prescribed due date, the Company expects to file the Q2 Form 10-Q on or before the fifth calendar day following the prescribed due date.
  • Co separately affirmed its regular quarterly dividend of $0.40 per share of common stock
  • Thursday, July 11, 2019

    Long trade : Antero Midstream (AM) +8% (7/19)

    • Antero Midstream increases its quarterly cash dividend to $0.3075 per share from $0.3025 per share
    Antero Midstream Corporation owns and operates midstream energy assets servicing rich gas production in North America. It owns and operates an integrated system of natural gas gathering pipelines, compression stations, processing and fractionation plants, and water handling and treatment assets in the Marcellus Shale and Utica Shale basins. 
    Sector: Energy

    Industry: Oil & Gas Midstream
    Founded in 2013
    HQ in Denver, Colorado
    Subsidiaries: Antero Midstream Partners LP, Antero Midstream Partners GP LLC
    http://www.anteromidstream.com



     




    Fastenal (FAST) reported earnings on Thur 11 July 19 (b/o)

    • Fastenal (FAST) as a distributor—and as one of the first industrial companies to report numbers this earnings season—its numbers will hold a lot of clues for investors regarding the health of the industrial economy
    ** charts before earnings **



     




    ** charts after earnings **










    Fastenal increases quarterly dividend to $0.22/share from $0.215/share (split adjusted)
    Fastenal misses by $0.01, reports revs in-line
    • Reports Q2 (Jun) earnings of $0.36 per share, $0.01 worse than the S&P Capital IQ Consensus of $0.37; revenues rose 7.9% year/year to $1.37 bln vs the $1.38 bln S&P Capital IQ Consensus.
    • "Our gross profit, as a percentage of net sales, declined 180 basis points to 46.9% in the second quarter of 2019 from 48.7% in the second quarter of 2018. The most significant factors behind the decline in our gross profit percentage in the period were the impacts of customer and product mix and net inflation on product margins, the latter of which had a larger negative impact on our margin than in the first quarter of 2019. While we successfully raised prices as one element of our strategy to offset tariffs placed to date on products sourced from China, those increases were not sufficient to also counter general inflation in the marketplace. We have taken additional actions in the third quarter of 2019 to counter the broader pressures we are experiencing on our costs as well as the additional tariffs that were levied on China-sourced products in May 2019."